参考文献/References:
[1] Dhingra A,Garg A,Kaur S,et al. Epidemiology of heart failure with preserved ejection fraction[J]. Curr Heart Fail Rep,2014,11(4):354-365.
[2] Lam CSP,Voors AA,de Boer RA,et al. Heart failure with preserved ejection fraction:from mechanisms to therapies[J]. Eur Heart J,2018,39(30):2780-2792.
[3] Sionis A. Comments on the 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Rev Espola Cardiol(Engl Ed),2016,69(12):1119-1125.
[4] Mulder BA,van Veldhuisen DJ,Crijns HJ,et al. Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation:insights from SENIORS[J]. Eur J Heart Fail,2012, 14(10):1171-1178.
[5]McMurray JJ,Iverson E,Donovan M, et al.Irbesartan in patients with heart failure and preserved ejection fraction.[J].N Engl J Med,2008,359(23):2456-2467.
[6] Yamamoto K,Origasa H,Hori M. Effects of carvedilol on heart failure with preserved ejection fraction:the Japanese Diastolic Heart Failure Study(J-DHF)[J]. Eur J Heart Fail,2013,15(1):110-118.
[7] Yancy CW,Jessup M,Bozkurt B,et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America[J]. J Am Coll Cardiol,2017,70(6):776-803.?
[8] Solomon SD,Claggett B,Lewis EF,et al. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure and preserved ejection fraction[J]. Eur Heart J,2016,37(5):455-462.
[9] Hoendermis ES,Liu LC,Hummel YM,et al. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial[J]. Eur Heart J,2015,36(38):2565-2573.
[10] 赵跃华,王占启,石向欣,等. 沙库巴曲缬沙坦(LCZ696)治疗心力衰竭的研究进展[J]. 临床心血管病杂志,2019,35(6):491-494.
[11] Del Trigo M,Rodés-Cabau J. Transcatheter structural heart interventions for the treatment of chronic heart failure[J]. Circ Cardiovasc Interv,2015,8(7):e001943.
[12] 顾东风,黄广勇,吴锡桂,等. 中国心力衰竭流行病学调查及其患病率[J]. 中华心血管病杂志,2003,31(1):3-6.
[13] van Riet EE,Hoes AW,Wagenaar KP,et al. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review[J]. Eur J Heart Fail,2016,18(3):242-252.
[14] Shaltout HA,Eggebeen J,Marsh AP,et al. Effects of supervised exercise and dietary nitrate in older adults with controlled hypertension and/or heart failure with preserved ejection fraction[J]. Nitric Oxide,2017,69:78-90.
[15] Fukuta H,Goto T,Wakami K,et al. Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction:a meta-analysis of randomized controlled trials[J]. Eur J Prev Cardiol,2016,23(1):78-85.
[16] 钟小燕,白晶,罗荣. 我国“互联网+医疗”服务模式[J]. 中国卫生事业管理,2019, 36(1):30-32,38.
[17] Kalter-Leibovici O,Freimark D,Freedman LS,et al. Disease management in the treatment of patients with chronic heart failure who have universal access to health care:a randomized controlled trial[J]. BMC Med,2017,15(1):90.
[18] Bashi N,Karunanithi M,Fatehi F,et al. Remote monitoring of patients with heart failure: an overview of systematic reviews[J]. J Med Internet Res,2017,19(1):e18.
[19] Herold R,van den Berg N,D?rr M,et al. Telemedical care and monitoring for patients with chronic heart failure has a positive effect on survival[J]. Health Serv Res,2018,53(1):532-555.
相似文献/References:
[1]王继航 赵施皓 李开亮 田进文 李玉龙 付士辉 沈明志 邓珏琳.远程医疗在高血压病管理中的研究进展[J].心血管病学进展,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
WANG Jihang,ZHAO Shihao,LI Kailiang,et al.Telemedicine in Hypertension Management[J].Advances in Cardiovascular Diseases,2019,(3):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
[2]菲尔凯提·玉山江李昊穆叶赛·尼加提.射血分数保留性心力衰竭合并糖尿病的研究进展[J].心血管病学进展,2020,(4):373.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.011]
FEIERKAITI·Yushanjiang,LIHao,MUYESAI.Nijiati.Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2020,(3):373.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.011]
[3]高可 杨蕾 姚新叶 郑小璞.射血分数保留性心力衰竭动物模型的研究进展[J].心血管病学进展,2020,(8):834.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.013]
GAO Ke,YANG Lei,YAO Xinye,et al.Advances in Animal Models ofHeart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2020,(3):834.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.013]
[4]刘春秋 熊双 刘剑刚 董国菊.射血分数保留性心力衰竭的诊断的研究进展[J].心血管病学进展,2021,(9):784.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
LIU Chunqiu,XIONG Shuang,LIU Jiangang,et al.Diagnosis of Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2021,(3):784.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[5]宋雨 李耘 马丽娜.老年人衰弱和射血分数保留性心力衰竭病理生理学机制的研究进展[J].心血管病学进展,2022,(1):38.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.010]
SONG Yu,LI Yun,MA Lina.Pathophysiological Mechanisms of Frailty and Heart Failure with Preserved Ejection Fraction in the Elderly[J].Advances in Cardiovascular Diseases,2022,(3):38.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.010]
[6]赵菲 刘永铭.抗炎类药物对射血分数保留性心力衰竭患者心外膜脂肪组织的影响[J].心血管病学进展,2022,(1):41.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.011]
ZHAO Fei,LIU Yongming.Effects of Anti-Inflammatory Drugs on Epicardial Adipose Tissue in Patients with Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2022,(3):41.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.011]
[7]张文珺 牛小伟 刘永铭.m6A甲基化在射血分数保留性心力衰竭中的作用的研究进展[J].心血管病学进展,2022,(1):44.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.012]
ZHANG Wenjun,NIU Xiaowei,LIU Yongming.m6A RNA Methylation in Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2022,(3):44.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.012]
[8]聂琼 吴镜.射血分数保留性心力衰竭：从机制到治疗[J].心血管病学进展,2022,(3):258.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2022.03.0170]
NIE Qiong,WU Jing.Heart Failure with Preserved Ejection Fraction:from Mechanism to Treatment[J].Advances in Cardiovascular Diseases,2022,(3):258.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2022.03.0170]
[9]卢甜甜 张轶.射血分数保留性心力衰竭左心室心肌力学变化及评估的研究进展[J].心血管病学进展,2022,(4):331.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.011]
LU Tiantian,ZHANG Yi?/html>.Changes and Evaluation of Left Ventricular Myocardial Mechanical?n Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2022,(3):331.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.011]
[10]时利英 蒋晖.运动训练在射血分数保留性心力衰竭的应用进展[J].心血管病学进展,2022,(4):344.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.014]
SHI liying,JIANG hui.Exercise-Based Rehabilitation in Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2022,(3):344.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.014]